Mercury toxicity is a highly interesting topic in biomedicine due to the severe endpoints and treatment limitations. Selenite serves as an antagonist of mercury toxicity, but the molecular mechanism of detoxification is not clear. Inhibition of the selenoenzyme thioredoxin reductase (TrxR) is a suggested mechanism of toxicity. Here, we demonstrated enhanced inhibition of activity by inorganic and organic mercury compounds in NADPH-reduced TrxR, consistent with binding of mercury also to the active site selenolthiol. On treatment with 5 M selenite and NADPH, TrxR inactivated by HgCl 2 displayed almost full recovery of activity. Structural analysis indicated that mercury was complexed with TrxR, but enzymegenerated selenide removed mercury as mercury selenide, regenerating the active site selenocysteine and cysteine residues required for activity. The antagonistic effects on TrxR inhibition were extended to endogenous antioxidants, such as GSH, and clinically used exogenous chelating agents BAL, DMPS, DMSA, and ␣-lipoic acid. Consistent with the in vitro results, recovery of TrxR activity and cell viability by selenite was observed in HgCl 2 -treated HEK 293 cells. These results stress the role of TrxR as a target of mercurials and provide the mechanism of selenite as a detoxification agent for mercury poisoning.-Carvalho, C. M. L., Lu, J., Zhang, X., Arnér, E. S. J., Holmgren, A. Effects of selenite and chelating agents on mammalian thioredoxin reductase inhibited by mercury: implications for treatment of mercury poisoning. FASEB J. 25, 370 -381 (2011). www.fasebj.org
Mercury toxicity causes damage to the brain, the kidneys, and the immune system, being a worldwide public health concern. Chemical compounds of mercury are no longer used as medicines, fungicides, or antiseptics. However, occupational exposure to high levels still happens, and general population exposure occurs through the consumption of fish containing methylmercury, the use of dental amalgam fillings that release mercury vapor, and vaccines with thimerosal as preservative (1) (2) (3) (4) . Although mercurials are not new toxicants, there is a significant lack of knowledge about their mechanisms of toxicity, as well as about good strategies of treatment.
The thioredoxin (Trx) system, comprising Trx, Trx reductase (TrxR), and NADPH, is critical for cellular stress response, protein repair, and protection against oxidative damage. The Trx system is upstream of a network of pathways related to cell survival and proliferation, and the inhibition of this system as an early event would trigger a series of downstream cellular signaling that can end up in cell death (5) .
TrxR is a dimeric enzyme showing subunits with M r of 58,000 (6, 7) with a redox active disulfide and a flavin adenine dinucleotide (FAD) in each monomer. It belongs to a larger family of pyridine nucleotide-disulfide oxidoreductases, which includes the closely related enzymes lipoamide dehydrogenase, glutathione reductase, trypanothione reductase, and mercuric reductase (8) . The carboxy-terminal motif of mammalian TrxR, Gly-Cys-SeCys-Gly, contains a selenocysteine (Sec) essential for the catalytic activity of the enzyme (9, 10) . Since the Sec is a highly reactive nucleophile with a low pKa value, mammalian TrxRs have a wide substrate specificity, and besides reducing Trx from different species, they reduce several low-molecular-weight disulfide substrates, such as 5,5Ј-dithiobis-(2-nitrobenzoic acid) (DTNB) and ␣-lipoic acid (ALA; 6,8-dimercaptooctanoic acid), and nondisulfide substrates, including lipid hydroperoxides, alloxan, selenodiglutathione (11) , and selenite (12) .
Selenium is an essential trace element for higher eukaryotes, and among the selenoproteins, mammalian TrxR shows increased activity with selenium supplementation at the nutritional-to supranutritional-range level, with consequent benefits due to defense against oxidative stress and/or the cell signaling pathways (13) . The interaction of selenium with mercury was first reported by Parizek and Ostadalova (14) , and despite the large number of reports on mercury and selenium interaction (for reviews, see refs. 15, 16) , there is still a lack of molecular mechanisms for selenium antagonism of mercurial compounds. Also, it has been increasingly evident that thiols, dithiols, nutritional factors, and ligand interactions play a significant role in the toxicology of mercury (17) . For instance, glutathione (GSH) is the primary thiol mechanism defense against mercury poisoning, since GSH is involved in biliary excretion of mercurials, especially monomethylmercury chloride (MeHg; refs. 18, 19) . Moreover, a few chelating agents have been used pharmacologically in the treatment of mercury toxicity. British antilewisite (BAL; 2,3-dimercapto-1-propanol) is historically the best known drug (20) studied in toxicology research (21) . It has been used as a chelating agent for heavy metals such as mercury, lead, and arsenic. However, its use has been discontinued due to severe side effects and low therapeutic index (22 (17, 25) , although they do not chelate mercury in the brain. ALA, on the contrary, can access all tissues of the body, including the central nervous system.
In our previous work, we proved that mercurial compounds either in vitro or in cellular systems preferentially target the Trx system, with TrxR being inhibited to a great extent (26) . The aim of this study was to clarify how mercury affects the structure and function of TrxR and to identify endogenous or exogenous compounds that can reverse the strong inhibition of TrxR caused by mercurials.
MATERIALS AND METHODS

Materials and enzymes
The preparation of recombinant rat TrxR was carried out as described previously (27) . The protein had 30 -50% specific activity of wild-type TrxR as determined by the DTNB assay, and concentrations used are reported for active enzyme. The preparation of wild-type human Trx was previously published (26) . Human Trx was DTT treated to obtain the fully reduced form and followed desalting on Sephadex G-25 containing NAP-5 columns (Amersham Biosciences, Uppsala, Sweden) pre-equilibrated with 50 mM Tris⅐Cl:1 mM EDTA (TE) buffer (pH 7.5), to remove excess DTT. Protein concentration of eluted protein solution was then determined. Insulin, GSH, DTNB, mercuric chloride (HgCl 2 ), and MeHg were purchased from Sigma (St. Louis, MO, USA). N-biotinoyl-NЈ-(iodoacetyl)-ethylenediamine (BIAM) was supplied by Invitrogen and iodoacetamide by Sigma. HgCl 2 and MeHg were prepared as 100 mM stocks in MiliQ water and DMSO, respectively. The ratio of mercurials used for TrxR treatment was calculated by taking into consideration the total [truncated (T) and full-length (FL) protein] concentration of the enzyme, determined by absorbance reading at 280 and 310 nm.
For immunoblotting, the antibodies used were streptavidin horseradish peroxidase (HRP; Dako, Glostrup, Denmark); anti-rat TrxR primary antibody from rabbit (28) and goat anti-rabbit HRP secondary antibody (SDS Biosciences, Falkenberg, Sweden).
Trx system activity determination by insulin reduction assay
Activity of the Trx system was determined by modification of a method previously described (29) . In disposable semimicro-UV cuvettes (Plastibrand, Wertheim, Germany), 12.5 nM recombinant rat TrxR and 2 or 3 M hTrx were preincubated with HgCl 2 or MeHg of different concentrations and 200 M NADPH in 50 mM Tris-HCl, pH 7.5 (final volume 500 l) for 5 min at room temperature. Then 100 l of Tris buffer containing insulin and NADPH (final concentration 160 and 200 M, respectively) was added, and absorbance at 340 nm was followed in an Ultrospec 3000 spectrophotometer (GE Healthcare, Little Chalfont, UK). Activity was calculated as the linear change in absorbance over the initial 15 min.
Trx system activity determination by selenite reduction assay
Activity of the Trx system was determined by modification of a method previously described (12) . Sodium selenite (Fluka, Buchs, Switzerland) concentration was kept at 40 M unless otherwise stated. Measurements of selenite reduction were performed in 50 mM Tris-HCl and 1 mM EDTA (pH 7.5) using 200 M NADPH. FL TrxR concentration was kept at 12.5 nM, and Trx was added at a concentration of 2 M to improve the rate of reaction. Reference cells containing either no TrxR or no selenite were run as blanks. Activity was calculated by comparing the highest linear slope attained with each preparation in the 0-to 15-min interval with the control TrxR.
Gel electrophoresis
Untreated and mercurial compound-treated TrxR protein samples were loaded onto 12% Bis-Tris NuPAGE gel (Invitrogen Life Technologies, Carlsbad, CA, USA) and separated using MES SDS running buffer. Sample buffer was NuPAGE LDS sample buffer (4ϫ); marker solution was See Blue Plus 2 prestained standard (Invitrogen).
Mass spectra analysis
Human TrxR was used as prepared or treated with NADPH to obtain the reduced form. Then the protein was treated with HgCl 2 , MeHg, selenite, or combinations thereof, and excess of treatment compound was removed by another desalting process (1 or 2 steps as indicated in each situation). Prior to mass spectra analysis, all samples were concentrated and pre-equilibrated with MiliQ water by using NAP-5 columns or Nanosep vials (Pall Corporation, Port Washington, NY, USA). The buffer-free solutions were diluted to a final protein concentration of ϳ2 M with 50% acetonitrile and 0.1% formic acid. Data were acquired on a quadrupole time-offlight (QTOF) Ultima API spectrometer (Waters Corp. Milford, MA, USA) equipped with a standard Z-spray API source in positive mode (at the Protein Analysis Center, Karolinska Institute). Samples were introduced from the metal-coated borosilicate glass capillary needle (Proxeon Biosystems A/S, Odense, Denmark), and the capillary voltage was 1.5 kV. The instrument was calibrated between 300 and 1400 m/z with myoglobin before the run. The data were sampled over a mass range between 300 and 3000 m/z with a scan of 1 s for ϳ5 min. The spectra were combined and deconvoluted to 0 charged ions (average mass) using Maxlynx 4.0 software (Waters).
Chelant treatment of inhibited TrxR
TrxR treated with HgCl 2 or MeHg was incubated with different chelating agents ( Fig. 1) : BAL, reduced and oxidized ALA, DMPS, and DMSA (Sigma). A 100 mM BAL solution was prepared in ethanol, and this was used to obtain the work solution of 10 mM in MiliQ water. The same procedure was applied to the reduced lipoic acid, whereas the oxidized form of this compound was diluted to 10 mM with ethanol. DMPS was directly dissolved in water to a concentration of 10 mM. Since DMSA solubility in water was very low, the 10 mM working solution was prepared in 99.7% ethanol. All chelating agents were readily used after their preparation. Final concentrations of chelating agents in the reaction media containing mercurial-inhibited TrxR (ratio of 4 and 32 for HgCl 2 and MeHg, respectively) was 40 M unless otherwise stated. The activity of TrxR was evaluated by using the insulin assay. The control enzyme activity was compared with the mercury-inhibited preparations with and without chelating treatment; a second control was also run by adding chelating agent to nontreated enzyme.
BIAM-labeling assay
BIAM stock solution at a concentration of 100 M was freshly prepared in 100 mM Tris-HCl and 1 mM EDTA (pH 6.5) for each experiment. In an Eppendorf tube, NADPH-reduced recombinant rat TrxR (0.95 M) was incubated with HgCl 2 or MeHg in 20 mM Tris-HCl, 1 mM EDTA (pH 7.5), and 200 M NADPH at room temperature. After 15 min, a 3-l aliquot was withdrawn and mixed with 20 M BIAM in 100 mM Tris-HCL and 1 mM EDTA (pH 6.5) to a final volume of 30 l; solutions were incubated at 37°C for 15 min. Alkylation of free selenol was obtained by adding freshly prepared iodoacetamide solution to a final concentration of 50 M. The protein samples were then denatured in SDS sample buffer and subjected to SDS-PAGE and Western blot analysis. The biotin was detected by HRP-conjugated streptavidin using the enhanced chemiluminescence system (Perkin-Elmer Life Sciences, Upplands Väsby, Sweden). Membranes were gently stripped with a buffer containing 63 mM Tris (pH 6.5) and 2% SDS for 45 min at 55°C with 3 (1 min) cycles of shaking. Then they were reprobed with polyclonal anti-rat TrxR1 antibody purified from rabbit antiserum against rat liver TrxR1 (28); Western lightning chemiluminescence reagent plus (Perkin Elmer Life and Analytical Sciences) was applied to membrane under light protection and after 5 min chemiluminescence emission was detected using a Chemi Doc XRS with a CCD camera and Quantity One software (Bio-Rad, Sundbyberg, Sweden). Protein levels were compared using the same detection system. For the concentrations of mercurial compounds used, the activity of the enzyme was determined as described.
Cell viability assay
HEK293T cells were plated at 37°C in 96-microwell plates and allowed to grow in RPMI 1640 medium for 24 h. Then, the medium was changed to the growth medium containing HgCl 2 together with different concentrations of selenite. The cells were treated for 24 h, and cell viability was measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method (26) .
TrxR activity assay in the cell lysates
HEK293T cells were plated in 100-mm Petri dishes in the normal growth medium. Then, the cells were treated with HgCl 2 and different concentration of selenite for 24 h. Following treatment, the cells were washed with PBS twice and lysed in the cell lysis buffer: 25 mM Tris-HCl (pH 7.5), 100 mM NaCl, 2.5 mM EDTA, 2.5 mM EGTA, 20 mM NaF, 1 mM Na 3 VO 4 , 20 mM sodium ␤-glycerophosphate, 10 mM sodium pyrophosphate, and 0.5% Triton X-100 containing protease inhibitor cocktails (Roche Diagnostics, Mannheim, Germany). The protein concentration was determined by Bio-Rad DC protein assay. TrxR activity in cell lysates was measured by a sensitive method using fluorescently labeled insulin as the substrate, which is based on the insulin assay (ref. 7 and unpublished results).
RESULTS
Effects of NADPH and GSH on the inhibition of TrxR by HgCl 2 and MeHg
Mercurials inhibit TrxR activity (26) , with the inorganic compound HgCl 2 being much more active than the organic MeHg as an inhibitor ( Fig. 2A, B) . Thus, a molar ratio of 2.5 of MeHg added to nonreduced TrxR did not cause significant effects on TrxR activity determined in a Trx-dependent activity assay, whereas the same ratio for HgCl 2 caused a 50% decrease in activity. When fully reduced enzyme was generated by preincubation with excess NADPH, HgCl 2 at the same ratio of 2.5 completely inactivated TrxR, and also MeHg was more effective over the reduced enzyme. In the presence of NADPH, a ratio of 2 HgCl 2 molecules to 1 TrxR dimer led to a virtually inactive enzyme, while in the case of MeHg (Fig. 2B ), a ratio of 16 molecules/dimer was needed to get the same level of enzyme inactivation. These results show that the active site dithiol and selenolthiol of TrxR (10) are the most effective binding sites of the mercurials.
GSH forms complexes with both mercurial compounds, causing their depletion in living organisms (30); therefore, we tested a possible protective effect on TrxR inhibition. From Fig. 2 , it can be seen that 1 mM GSH interfered with the inhibition of TrxR caused by mercury, particularly with MeHg, whereas GSH prevented the full inhibition in both the absence and presence of NADPH.
Analysis of mercury interactions with TrxR: adduct formation
Mercury in oxidation state I or II is a potent electrophile, and the inactivation of TrxR may be a consequence of an oxidative event or, more likely, binding effects. To understand in depth the effect on the enzyme, samples that had been incubated with HgCl 2 and MeHg and desalted were analyzed by mass spectrometry and compared with a control of nontreated enzyme. Mass spectra analysis results ( Fig. 3 and Table 1 ) clearly indicate that the reaction leading to inactivation of TrxR involved the direct binding of mercury to TrxR. Adduct formation was facilitated by the presence of NADPH, as the number of bound mercury atoms detected increased when compared with the samples treated with mercurials but without NADPH (Fig. 3) . Moreover, the formation of TrxR adducts with mercurials did not always result in inactivation of the enzyme, since in the absence of NADPH, TrxR bound MeHg but still had activity (Table 1) . On the other hand, Hg 2ϩ binding to TrxR was more effective and destructive of catalytic activity independent of its oxidation state ( Table 1) .
The interpretation of spectra considered the coexistence in the recombinant enzyme preparation of 2 TrxR forms, T and FL, that have a molecular mass difference close to that of Hg 2ϩ . The correspondence between protein molecular mass and number of mercurial molecules reacting with TrxR is presented in Table 1 .
BIAM labeling-Sec as a target
In the next step, we aimed to identify amino acid residues in TrxR targeted by mercury. To verify whether there was involvement of the active site selenol of Sec in mercurial binding of TrxR, BIAMlabeling reactions were carried out at low pH (6.5). Free Sec is reactive and alkylated due to its low pKa value in contrast to Cys thiols, but a Sec that is oxidized or chemically modified by mercury binding is not labeled.
The images in Fig. 4A , B show the HRPstreptavidin-blotted bands of the TrxR monomer corresponding to 55 kDa. The free selenol decreased in intensity with the increase in mercury inhibitor concentrations. For HgCl 2, the chemiluminescence of HRP-conjugated streptavidin-detecting alkylated Sec indicated a fast and almost complete inhibition at a molar ratio of 4, while for MeHg, this happens at a ratio of 8, lower figures than could be anticipated from the results obtained in the insulin reduction assay, but in good agreement with the selenite reduction assay results for MeHg (see below and 
Selenite effect on the activity of TrxR inhibited by mercury
Selenium compounds are implicated in protection from mercury toxicity but are also substrates for mammalian TrxR, which prompted us to use selenite as an alternative substrate for the evaluation of the catalytic activity of TrxR after treatment with HgCl 2 and MeHg.
With the selenite reduction assay (Fig. 5) , TrxR inhibition by MeHg was dose dependent and gave results similar to the insulin assay (Fig. 2) , with complete loss of activity for the NADPH-treated reduced enzyme. However, the results obtained with TrxR , and 800 nM (B) and incubated for 5 min. Activity was compared with control enzyme following the same protocol but with no added mercury. Interference on inhibition by GSH was evaluated by adding 1 mM of a freshly prepared solution after mercury treatment and before activity determination. Activity was measured by insulin reduction assay, as described in Materials and Methods. Data points are means of Ն3 independent determinations. I, inhibitor. treated with HgCl 2 were unexpected, since no inhibition could be detected even with the NADPH-reduced enzyme and excess inhibitor, in sharp contrast to results in Fig. 2 .
To analyze whether selenite itself or the product selenide caused the effect, we applied the insulin assay. However, the insulin assay could not be directly performed after the addition of selenite, as it blocks insulin-disulfide reduction by the Trx system (12). Hence, a protocol encompassing purification and desalting steps was designed (Fig. 6A) , and the effects of HgCl 2 and HgCl 2 plus selenite were evaluated in parallel. One of the 3 independent experiments carried out was also used to take samples for BIAM labeling (Fig.  6C) . The experiment started with the same enzyme preparation that was incubated with HgCl 2 and further divided into 2 portions; selenite was added to one, buffer alone to the other. The TrxR was desalted by passage through NAP-5 columns, including a second passage through new NAP-5 columns to eliminate traces of reagents. Along the process, protein concentration was measured, and aliquots were taken to determine activity. The results obtained (Fig. 6B) show that TrxR became inactive in the insulin assay when incubated with HgCl 2 at a ratio of 8 and remained unchanged after desalting, but after selenite treatment, there was a significant recovery of activity. Even in the absence of any purification step, selenite addition resulted in activity recovery (21% of control activity), which increased to 77 and 71% activity recovery with 1 and 2 passages through the NAP-5 columns, respectively.
The TrxR samples used in the insulin assay activity determination (Fig. 6A, B) were also used to run Western blot analysis (Fig. 6C) and to detect the effect of treatments and purification on the Sec residue in the active site. Samples were run in duplicate, with the first set treated with NADPH immediately before BIAM-labeling to ensure a fully reduced active site available for alkylation, as it was observed that the addition of selenium to TrxR (control without any purification step) samples systematically led to band loss (immunoblotting results not displayed). The most significant observation was that the samples treated with HgCl 2 and selenite followed by NADPH showed a stronger band, implying more free Sec.
The results obtained by 2 activity determination methods confirmed that selenite reactivated HgCl 2 - inhibited TrxR and indicated that the process resulted in displacement of mercury from the active site Sec residue.
Structural effects of selenite on TrxR-MS spectra analysis reveals direct interaction
The evidence that selenite can reactivate the TrxR inhibited by inorganic mercury compounds suggested that selenide, a product of selenite reduction, could remove the Hg from the active site of the enzyme. Nevertheless, mass spectra obtained with samples from the experiment described in Fig. 6A showed selenite treatment resulted in new peaks (Fig. 7) , which coexisted with the mercury peaks. A control TrxR preparation treated with selenium showed that selenite interaction with the enzyme took place in the absence of mercury (Fig. 7) .
Chelating agents and their effects on mercury-inhibited TrxR
Chelating agents not only enhance excretion but, in some cases, can prevent the metal from binding to target molecules, and were tested together with TrxR.
As shown in Fig. 8 , BAL, DMPS, and ALA were very effective in recovering TrxR activity after HgCl 2 inhibition. With these molecules, efficacy was close to 90% and was followed by DMSA with 72% recovery, providing that the enzyme was freshly NADPH-reduced; otherwise, DMSA became ineffective (Ͻ2.5% activity recovery).
BAL was an antidote with more activity for MeHginhibited TrxR, which should be related to its higher lipophilicity, although the percentage of recovery was only half (46%) of that displayed for the inorganic form of mercury. ALA was ineffective in the oxidized form, while the reduced form of the compound was active toward the inorganic form of mercury.
Comparison of the efficiency of selenium and chelating agents
As BAL was the most effective antidote for recovery of HgCl 2 -inhibited TrxR, we investigated the effects of different concentrations. The effect of BAL was dose dependent, as shown by Fig. 9 . A comparison of selenite with BAL showed that the effect of selenite was remarkable, as a concentration of 5 M led to full activity of Effect of selenite on HgCl 2 -inhibited TrxR. A) NADPH-reduced TrxR (25 nM active protein) was treated with 8ϫ HgCl 2 , and activity was analyzed by the insulin reduction assay at each step of the process. Sample was divided into 2 portions; 1 portion was treated with selenite, and NAP-5 columns were used to remove excess mercury and selenium. This step was further repeated to ensure complete removal and no interference of selenite on activity determination. B) A range of 3-5 activity determinations in 3 independent experiments was carried out; data points presented are average Ϯ se values. C) Western blot analysis of samples from A to detect the effect of treatments and purification on the Sec active site. Samples were run in duplicate; first set was treated with NADPH immediately before BIAM labeling to ensure a fully reduced active site available for alkylation. Western blot was performed twice with identical results.
TrxR, while with BAL, it was estimated that a concentration of 50 M was needed to obtain an identical effect. Selenite at a concentration of 0.5-1 M was effective as any chelating agent tested for reactivation of HgCl 2 -inactivated TrxR (Fig. 8) .
Recovery of TrxR activity and cell viability by selenite in HgCl 2 -treated cells
To examine whether mercury-inhibited TrxR activity can be reactivated by selenite in the cells, we treated HEK293T with sodium selenite together with HgCl 2 for 24 h and measured TrxR activity and cell viability (Fig. 10) . Consistent with previous observation in HeLa cells (26) , treatment with HgCl 2 caused a dramatic decrease of TrxR activity. Inter- (Fig. 10A ). The cell viability tested in the 96-well plates also exhibited the same trend that selenite supplementation increased cell viability for HEK293T cells treated with 5 M mercury, but not for the cells treated with 10 M mercury (Fig. 10B) . Only higher concentration of selenite (Ͼ4 M) had some effects (Fig. 10B ), but treatment with higher concentration of selenite alone could significantly inhibit HEK 293T cell growth (8 M) (Fig. 10C) . Taken together, selenite addition could recover cell viability after HgCl 2 exposure. Moreover, the beneficial effect on cell viability of selenite was dependent on exposure time with mercury. When HEK293T cells were pretreated with 5 M HgCl 2 for 9 h, selenite supplementation (0.5-8 M) increased cell viability. This effect did not occur for HEK 293T cells treated with 5 M HgCl 2 for 24 h (Fig. 10D) .
DISCUSSION
In this study, we have characterized the effects of mercury compounds on TrxR, an essential selenoenzyme with a head-to-tail structure (Fig. 11) . Titration with HgCl 2 showed that a ratio of 2 was sufficient to inactivate the reduced enzyme (see Fig. 2A ), which means that 1 mercury molecule is enough to block the active site and the activity, most likely by bridging Cys and Sec in the active site. A lower affinity of MeHg for the reduced TrxR was observed. Multiple interactions were detected between mercurials and TrxR from MS analysis. The TrxR catalytic site has 3 cysteine amino acids, Cys 59 and Cys 64, adjacent to FAD in the inner portion of the active site (Fig. 11) , and Cys 497 and Sec 498 (9, 10), but in the structure of the protein, there are an additional 11 Cys residues (9), some exposed to the surface of the protein, that can also react with mercurial compounds. A dose-related increase in mercury lead to the decrease in BIAM labeling of free selenol (ϪSeH), as well as to a decline in catalytic activity,
are the first to be affected due to the presence of the Sec selenol with a lower pK a than thiols.
Selenium has been reported to reduce the toxicity induced by mercury (14, 15, (31) (32) (33) (34) (35) , although there are also reports to the contrary (36 -39) . Basically, its effects in vivo have been correlated to a redistribution of mercury that results in a lower level of toxicity (for a review, see ref. 40 ). Our results show that selenite in the presence of NADPH regenerated the activity of HgCl 2 -inactivated TrxR. On the other hand, the results obtained with MeHg-inhibited TrxR indicated that selenite cannot prevent the decay of activity caused by this organic compound. Thus, the oxidation state of mercury and the size of the molecule are important variables to be considered. In fact, different selenium compounds can generate selenide, but not all mercurials react directly with it. The different results we obtained with HgCl 2 and with MeHg indicate that organomercurials must be converted to inorganic forms in order for living organisms to benefit from selenium's detoxifying effects; otherwise, the addition of selenium can worsen the toxic effects. TrxR was inactivated by HgCl 2 prior to selenite reactivation, and this indicates enzyme involvement, rather than a simple reaction between mercury and selenium. This is remarkable and helps to explain why several patients severely exposed to inorganic forms of mercury (for instance, by dental amalgams) experienced improved health when taking selenium supplements (41) .
The main visible effect of selenium treatment evidenced by MS is the formation of new adducts containing selenium. The mechanism for mammalian TrxR inhibition with HgCl 2 and respective reactivation on selenite treatment is proposed in Fig. 11 and assumes that the addition of selenite to the reaction medium in the presence of NADPH and TrxR will generate selenide (12) . The formation of selenide in mammalian tissues is very important for the physiological effects of selenium compounds and a key step for the synthesis of selenoproteins; and also, erythrocytes rapidly take up selenite and transport selenide back to the plasma (42) .
In the presence of NADPH, the selenenylsulfide receives electrons via the FAD and the redox-active dithiol of the first TrxR subunit to produce a sulfhydryl and a selenol in the second subunit. The selenolate would be the main target of the Hg 2ϩ , the result being a TrxR selenylsulfide adduct with Hg that could be attacked by Cys 497. Because of the occurrence of diselenide-bonded TrxR that was verified for the most abundant peaks, except for the third dominant mercury adduct at a molecular weight of 55,460 (see Fig. 7 ), as well as the restoration of TrxR activity, it was considered a 2-step mechanism. First, selenium (as HSe Ϫ ) was added to the TrxR-Hg adducts, with displacement of mercury from the active selenol and formation of mercury (II) selenide. At this point, we can transiently consider a selenolate anion or eventually a selenolthiol. Second, it is plausible that excess of selenide promotes the addition of a second selenium molecule to TrxR, as detected by the mass spectra, although it is not clear how this interaction is established. In summary, selenite reactivates HgCl 2 -TrxR by displacing mercury from the active site, giving rise to mercury selenide (HgSe) and regenerating the TrxR selenol. HgSe is a very stable compound and less toxic than elemental or many organometallic or inorganic mercurials. Several authors have followed the formation of HgSe in plasma or blood, and others report the need of a protein in the process; however, the protein involved has not been identified (43) (44) (45) . In fact, many researchers have considered the formation of this complex and the interaction of selenium with mercury strictly from the chemical species reactivity, sometimes forgetting that in living organisms, selenium exists mainly in selenoproteins, including selenoenzymes, integrating antioxidant systems such as glutathione peroxidase, TrxR, etc. (16) .
Effects of chelating agents on mercury-inhibited TrxR were evaluated at the concentration of 40 M, which is close to the value attained in the human organism with a therapeutic dose of DMSA (30 mg/kg) but still far from the concentration of 100 M tested in cortical cells without signs of toxicity (46) . BAL, DMPS, DMSA, and ALA were very effective, with 70 to 90% recovery of TrxR activity after incubation with the inorganic compound HgCl 2 (Fig. 7) . DMSA effectiveness was lower, and the action of this compound was very sensitive to the fresh NADPH reduction of TrxR, and thus to the opening of the active site; this can be attributed to its highly charged carboxyl groups, which also prevent its passage through cell membranes (25) .
MeHg-inhibited TrxR was reactivated by BAL, but activity was lower, only 46% of the control value. The Figure 11 . Schematic diagram of the proposed mechanism for mammalian TrxR inactivation by mercury and reactivation by selenite. TrxR head-to-tail structure is not drawn to scale, and the structural modifications are oversimplified as they encompass only the interactions involving the active-site Sec and Cys residues. difference here is that BAL is an oily lipid (20) , whereas DMPS and DMSA are water-soluble solids (25) . As Fig.  8 shows, generally, all the antidotes have fewer effects on TrxR inhibited by MeHg, despite the fact that the interactions between MeHg and the enzymes of Trx system are usually more labile than those displayed by inorganic HgCl 2 (26) .
Interestingly, the clinical use of these antidotes has been shown to be useful with the inorganic forms of mercurials but not with the organic, and our results are consistent with that trend. For instance, the administration of ALA to rats led to up to 37-fold increase in excretion of inorganic mercury, but the same effect was not observed for MeHg (47) . Also, DMPS and DMSA are synthetic dithiols that are known to act preferentially in cases of intoxication by HgCl 2 (17) or other forms previously converted to Hg 2ϩ (48) . Moreover, Rush et al. (46) carried out a study with mixed neuronal and glial cell cultures and reported that DMPS and DMSA both attenuated mercury toxicity, but the protection was only provided against the HgCl 2 and was lacking against MeHg.
It has generally been assumed that the chelates of all dimercapto-chelating agents are formed by coordination of both sulfur atoms with the metal or metalloid. In fact, it was shown by NMR and potentiometric titrations of DMSA that Hg 2ϩ coordinates with the 2 sulfur atoms (49) (for molecular structures, see Fig. 1 ). The coordination of the complexes justifies the observations of the preference for the inorganic form of mercury and the null effect of ALA chelation in the oxidized form.
From the toxicological point of view, the effectiveness of ALA in the reduced form is noteworthy, as ALA currently represents the only potential chelating agent capable of accessing the central and peripheral nervous system (17) .
Overall, there was good agreement between the clinical observations in mercury intoxication and the treatment of TrxR inhibited by mercury. The fact that the compounds commonly used in chelating therapy for mercury intoxication can regenerate the activity of TrxR is of utmost significance, as it gives strength to the fact that the Trx system is a major target of mercury toxicity and the origin of major health problems.
The different behavior shown by selenite in comparison to BAL indicates that selenium is more effective in binding mercury (Fig. 9) , probably due to the fact that as a substrate, selenium is immediately directed to the TrxR active site, and this increases its specificity as a detoxicant. The effect of selenite is remarkable, as a concentration of 5 M leads to TrxR full activity, while with BAL, it is estimated that a concentration of 50 M will be needed to obtain an identical effect. Selenite in a concentration of 0.5-1 M is as effective as any chelating agent tested for HgCl 2 inactivation of TrxR displayed in Fig. 9 .
Reference selenium plasma levels in healthy human individuals range from 50 to 160 g/L (50), and this is equivalent to the solutions containing 0.5-2 M selenite; levels equivalent to 80 M selenite were also found in humans living in contaminated areas, and they are associated with toxic levels (50) . Probably, the concentration of 2 M selenite can be exceeded in vivo, as Hg-Se complex formation decreases selenium levels in the case of mercury contamination, and also, this complex is inert (16, 51) . Epidemiological studies on patients with excessive mercury from dental amalgam corroborate this assumption, as the researchers reported significantly lower blood selenium levels in people with disease symptoms in comparison with healthy subjects (52) . On the other hand, selenium availability for selenoprotein synthesis is also crucial for its replacement if selenoproteins are a target for mercurials, as is the case for TrxR.
In summary, we have demonstrated that selenite could reactivate mercury-inhibited TrxR activity in vitro. Moreover, in HEK cells, TrxR activity could be recovered, and the cell toxicity was strongly reduced with the supplementation of selenium to the cells treated with HgCl 2 . However, there was a limit to this effect, since cells treated with high concentrations of HgCl 2 could not be rescued. These results thus provide a fundamental basis for the evaluation of the benefits of selenite's therapeutic use in mercury toxicity.
